Putnam

Name

Putnam

Legal name

Putnam Associates LLC

Website

https://inizio.com

Company type

Private

Operating status

Operating

Headcount range

251–500 employees

Short description

Putnam is a Boston-based life sciences consulting firm within Inizio Advisory, serving pharmaceutical, biotechnology, and medical device companies with portfolio analytics, market access strategy, HEOR, and EU JCA preparation services for over 30 years.

Ownership category

akta.pro rank

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Strategic Consulting Services: Scientific and strategic consulting fees for life sciences companies seeking support with portfolio analytics, market development, go-to-market strategy, and value, pricing and access strategy. Revenue generated through project-based consulting engagements and retainer arrangements with pharmaceutical and biotech clients.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Putnam is a scientific and strategic consulting firm serving the global life sciences industry. It helps pharmaceutical, biotechnology, and medical device companies with portfolio analytics, market development, go-to-market strategy, and value, pricing and access strategy, alongside evidence generation, HTA preparation (including EU Joint Clinical Assessment), indirect treatment comparisons, and real-world evidence studies using the French SNDS database.

Product overview

Putnam operates as part of Inizio Advisory, a unified platform comprising five specialized business units (Inizio Ignite, Inizio Medical, Inizio Evoke, Inizio Engage, and Inizio Biotech) that offer integrated health and life sciences consulting services. The company provides end-to-end commercialization support from clinical development through launch and post-launch, powered by proprietary AI platforms including Navigator AI, STEM AI, iON AI, and the Intelligent Congress and Intelligent Commercialization solution suites. Key methodologies include the PICO Simulation Framework for HTA anticipation and Connected Performance Assessment for launch optimization. The portfolio also includes allegro., an accelerated learning program for medical communications professionals.

Differentiator

Problem solved

Functional benefit

Products and services

• Putnam Consulting Services Scientific and strategic consulting services helping global life sciences companies with portfolio analytics, market development, go-to-market strategy, and value, pricing and access strategy. Targeted at pharmaceutical, biotechnology, and medical device clients.
• Health Technology Assessment (HTA) and Joint Clinical Assessment (JCA) Preparation Services Consulting services supporting EU Joint Clinical Assessment and national HTA submissions, including the PICO Simulation Framework and Indirect Treatment Comparison (ITC) methodologies (network meta-analysis, MAIC, ML-NMR). Targeted at pharma, biotech, and rare disease developers.
• Real-World Evidence Studies (French SNDS Data) Real-world evidence studies using the French medico-administrative SNDS database and French hospital data, covering vascular, cardiovascular, oncology, infectious disease, and rare disease topics. Delivered to pharma and medical device clients including WL Gore, Roche, Vivet, Idorsia, Zambon, and Shockwave Medical.
• Connected Performance Assessment Integrated diagnostic consulting methodology combining field execution analysis, HCP perception assessment, and market behavior analysis to identify launch drift and commercial performance gaps. Targeted at pharma and biotech launch teams.

Quantifiable outcome

• $300M impact via enterprise-wide transformation for top 10 life sciences firm
• +2 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• WL GorecoreStrategic or Co-development PartnerPutnam/Creativ-Ceutical conducts real-world evidence studies for WL Gore on vascular treatments including peripheral aneurysm treatments (VIA 21), IBE devices, and superficial femoral artery lesions (POA), as well as portal hypertension treatment strategies (VIA 22) using French SNDS data.
• RochecoreStrategic or Co-development PartnerPutnam/Creativ-Ceutical performs real-world data analysis for Roche using French medico-administrative databases to support ACE model development for COVID-19 treatment evidence.
• VivetminorStrategic or Co-development PartnerReal-world evidence analysis of Wilson's disease patient treatment patterns in France conducted by Putnam/Creativ-Ceutical.
• IdorsiaminorStrategic or Co-development PartnerReal-world evidence study on chronic insomnia burden in France conducted using SNDS data.
• ZambonminorStrategic or Co-development PartnerStudy of bronchiolitis obliterans syndrome (BOS) occurrence and burden in lung and stem cell transplant patients in France.
• Shockwave MedicalcoreStrategic or Co-development PartnerMultiple real-world evidence studies including peripheral arterial disease (PAD) patient management and intravascular lithotripsy (IVL) for calcified coronary artery disease complications using French hospital data.

Scale indicators3 records

Recent moves4 records

Expansion highlights6 records

Direct peers

• Trinity Life Sciences: Life sciences commercialization consulting firm covering portfolio strategy, market access, HEOR, and launch excellence. Closely comparable to Putnam in therapeutic-area expertise and client mix across top pharma and emerging biotech.
• Health Advances: Strategy consulting firm exclusively focused on life sciences, providing commercial and strategic guidance to pharma, biotech, and medtech. Comparable to Putnam in therapeutic-area expertise, project-based delivery, and biotech-focused client segment.
• Simon-Kucher & Partners: Global consulting firm with deep expertise in pricing, market access, and commercial strategy for life sciences. Directly comparable to Putnam's value, pricing and access strategy practice and the most natural competitor for PICO/HTA-adjacent work.
• L.E.K. Consulting: Global strategy consulting firm with a large dedicated life sciences practice covering pharma strategy, M&A, and commercial due diligence. Comparable on project-based strategic engagements with life sciences clients and partner-led delivery model.
• Charles River Associates (CRA): Consulting firm with a Life Sciences practice providing economic and strategic analysis, HEOR, and litigation support to pharma/biotech. Comparable to Putnam in project-based advisory for pharma strategy and evidence generation.
• ClearView Healthcare Partners: Life sciences strategy consulting firm focused on pharmaceutical, biotech, and medical device clients across commercial strategy, market access, and HEOR. Closely comparable in scale, customer mix (top pharma + emerging biotech), and project-based service model.
• ZS Associates: Specialized management consulting firm serving pharma and biotech across strategy, sales, marketing, and analytics. Directly comparable to Putnam in serving top-20 pharma with project-based strategic engagements, though with stronger tech/analytics DNA.

Broad incumbents

• IQVIA: Global leader in life sciences technology, data, and consulting. Overlaps directly with Putnam across pharma strategy, HEOR, market access, and RWE consulting, but operates at much greater scale and breadth including clinical research and real-world data infrastructure.
• McKinsey & Company (Pharma Practice): Global strategy consulting firm with a substantial Pharma & Medical Products practice. Competes with Putnam for large pharma transformation and launch engagements at the top of the market with brand and scale advantages.
• Boston Consulting Group (Pharma Practice): Global strategy consulting firm with a Health Care practice covering pharma, biotech, and medtech. Competes with Putnam at the enterprise transformation and portfolio strategy tier, with broader capabilities but less specialization.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/putnam-associates

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Putnam